HF 101: Remote Hemodynamically-Guided Heart Failure Management-HF 101: Remote Hemodynamically-Guided Heart Failure Management

HF 101: Remote Hemodynamically-Guided Heart Failure Management

Video Transcription

Video Summary

Professor Michael Zile introduces an American College of Cardiology curriculum on remote, hemodynamically guided heart failure (HF) management using implantable pulmonary artery (PA) pressure monitors. He reviews HF prevalence, phenotypes by ejection fraction, and guideline-directed medical/device therapy (GDMT), noting persistent residual risk, high hospitalization rates, mortality, and costs despite modern drugs. Because symptoms occur late, rising PA pressures weeks earlier can predict decompensation, hospitalization, and mortality; both baseline pressures and pressure changes are prognostic. FDA/CMS-approved systems (Abbott CardioMEMS, Endotronix Cordella) enable remote monitoring, and trials (e.g., CHAMPION) show reduced HF hospitalizations via pressure-guided treatment adjustments.

Keywords

remote hemodynamically guided heart failure management

implantable pulmonary artery pressure monitor

CardioMEMS and Cordella systems

pressure-guided therapy to reduce HF hospitalizations (CHAMPION trial)

guideline-directed medical and device therapy (GDMT) for heart failure